Hormone replacement therapy
- 20 July 2002
- Vol. 325 (7356) , 113-114
- https://doi.org/10.1136/bmj.325.7356.113
Abstract
Footnotes JCS and MIW have been investigators in various clinical trials of hormone replacement therapy regimens. JCS is an investigator in the MRC women's hormones intervention secondary prevention (WHISP) trial. MIW is an investigator in the UK national trial of use of hormone replacement therapy in women with early breast cancer. They have attended meetings and lectured on hormone replacement therapy, sometimes with the support of various pharmaceutical companies.Keywords
This publication has 6 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable anginaJournal of the American College of Cardiology, 2002
- Cardiovascular effects of oestrogensThe Journal of Steroid Biochemistry and Molecular Biology, 2000
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.1997